Mazor, J&J, Globus Medical & more: 6 device company notes

Here are six key notes on orthopedic and spine device companies from the past week.

Advertisement

Mazor Robotics reported third quarter revenue at $17.2 million, more than year-over-year revenue.

 

Globus Medical reported third quarter financial results, with sales increasing 11.9 percent over the same period last year.

 

Johnson & Johnson broke ground on the new $180 million medical device plant in China.

 

Johnson & Johnson Health Wellness Solutions launched the Johnson & Johnson Health Partner platform to help patients prepare for and recover from knee and hip surgery.

 

François-Henri Reynaud is Safe Orthopaedics’ new chief financial and administrative officer.

 

Xtant Medical postponed its Nov. 8, 2017, release of third quarter financial results and now plans to release the results by Nov. 20 in conjunction with the filing of its 10-Q.

 

More articles on devices and implants:
Stryker, Smith & Nephew & more: 9 device company mergers, acquisitions and agreements
Global interventional spine devices market to expand at10.5% CAGR through 2021 — 4 notes
Mazor reports Q3 revenue at $17.2M, $3.7M net loss: 6 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.